Yulisar SE - Medikaloka Hermina MD Director
| HEAL Stock | IDR 1,450 20.00 1.36% |
Insider
Yulisar SE is MD Director of Medikaloka Hermina PT
| Age | 65 |
| Phone | 62 21 857 2525 |
| Web | https://www.herminahospitals.com |
Medikaloka Hermina Management Efficiency
The company has return on total asset (ROA) of 0.0704 % which means that it generated a profit of $0.0704 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1398 %, meaning that it generated $0.1398 on every $100 dollars invested by stockholders. Medikaloka Hermina's management efficiency ratios could be used to measure how well Medikaloka Hermina manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| SE MM | Mitra Keluarga Karyasehat | 43 | |
| Mudunsen Putra | Sumber Alfaria Trijaya | N/A | |
| Andya Daniswara | Elang Mahkota Teknologi | N/A | |
| Giatrycks Sianipar | Elang Mahkota Teknologi | 48 | |
| Saka Nainggolan | Elang Mahkota Teknologi | N/A | |
| Tri Sunu | Sumber Alfaria Trijaya | 51 | |
| MBA MBA | Mitra Keluarga Karyasehat | 53 | |
| Mochtar Riady | Siloam International Hospitals | 93 | |
| Sri Dewi | Elang Mahkota Teknologi | N/A | |
| Ryan Kaloh | Sumber Alfaria Trijaya | N/A | |
| Maria | Siloam International Hospitals | N/A | |
| Nur Rachman | Sumber Alfaria Trijaya | N/A | |
| Sri Novani | Sumber Alfaria Trijaya | N/A | |
| Gunawan Prajitno | Siloam International Hospitals | 49 | |
| Catherine Sabatini | Siloam International Hospitals | 31 | |
| Paulus Sujono | Siloam International Hospitals | N/A | |
| Joel Ellis | Siloam International Hospitals | 37 | |
| Amelia Hendra | Siloam International Hospitals | N/A | |
| Darjoto BSc | Siloam International Hospitals | 65 | |
Management Performance
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0704 |
Medikaloka Hermina Leadership Team
Elected by the shareholders, the Medikaloka Hermina's board of directors comprises two types of representatives: Medikaloka Hermina inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medikaloka. The board's role is to monitor Medikaloka Hermina's management team and ensure that shareholders' interests are well served. Medikaloka Hermina's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medikaloka Hermina's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arie Wahyudi, Head Legal | ||
| Binsar Simorangkir, Medical and Compliance Director | ||
| Joni Agus, Head Audit | ||
| Yulisar SE, MD Director | ||
| Husen Sutakaria, Vice President Commissioner | ||
| Muyi MM, Head Marketing | ||
| Darwin Noerhadi, Commissioner | ||
| Sri MM, Head Devel | ||
| Yulisar Khiat, Operational and General Director, Corporate Secretary | ||
| Alexander Rusli, Independent Commissioner | ||
| MB BA, Commissioner | ||
| Hastiyudo MBA, B Devel | ||
| Aristo Setiawidjaja, Strategic Development and Finance Director, Independent Director | ||
| Hasmoro, President Director | ||
| MM MHA, Pres Director | ||
| Paulus Gunawan, President Commissioner | ||
| Sudarsono, Commissioner | ||
| Heridadi, Independent Commissioner |
Medikaloka Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medikaloka Hermina a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0704 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 23.44 T | |||
| Shares Outstanding | 14.48 B | |||
| Shares Owned By Insiders | 51.07 % | |||
| Shares Owned By Institutions | 7.10 % | |||
| Price To Earning | 7.42 X | |||
| Price To Book | 6.72 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Medikaloka Stock
Medikaloka Hermina financial ratios help investors to determine whether Medikaloka Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medikaloka with respect to the benefits of owning Medikaloka Hermina security.